| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $68.6M | -20.9% |
| SG&A Expense | $24.7M | -15.3% |
| Operating Income | -$93.3M | +19.5% |
| Pre-tax Income | -$90.6M | +18.5% |
| Income Tax | $0 | — |
| Net Income | -$90.6M | +18.5% |
| EPS (Basic) | -$0.59 | +55.0% |
| EPS (Diluted) | -$0.59 | +55.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100.5M | +2225.9% |
| Short-term Investments | $57.1M | +0.0% |
| Current Assets | $105.6M | +56.7% |
| Total Assets | $146.9M | +22.5% |
| Current Liabilities | $15.4M | -3.4% |
| Total Liabilities | $23.7M | -12.7% |
| Stockholders' Equity | $123.3M | +32.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.3M | +24.6% |
| Capital Expenditures | $618K | -39.7% |
| Investing Cash Flow | $56.1M | +4858.7% |
| Financing Cash Flow | $108.4M | +127.0% |
| Free Cash Flow | -$68.9M | +24.7% |